Join Rok Sekirnik, as he delves into the latest advancements in mRNA vaccine and therapeutic production.
Speaker:
Rok Sekirnik, Head Process Development mRNA | pDNA, Sartorius BIA Separations
Key Takeaways:
- dsRNA stability depends on hydrogen bonding.
- Disrupting hydrogen bonding destabilizes dsRNA into individual RNA strands. Target mRNA is selectively isolated with affinity Oligo dT chromatography.
- This approach is scalable, high-recovery (more than 90%), and GMP compliant.
Abstract:
Production of mRNA vaccines and therapeutics with in vitro transcription (IVT) reactions can result in the generation of double-stranded RNA (dsRNA), which is immunogenic and can compromise mRNA efficacy and safety.
Sartorius BIA Separations introduces a novel dsRNA removal technique that selectively destabilizes dsRNA by targeting hydrogen bonding that is critical for dsRNA stability. After denaturation, contaminating RNA strands are removed with an established purification platform based on Oligo dT affinity chromatography. By only modulating the pH, this method enables controlled denaturation of dsRNA under non-hazardous conditions.
This approach enhances the removal of dsRNA contaminants, increases mRNA integrity, and reduces immunogenicity while offering a scalable, high-recovery alternative to traditional dsRNA purification methods, which suffer from low recovery and low selectivity. The results include improving the overall quality, safety, and manufacturability of mRNA products.
